Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

 Fujifilm Medical Systems U.S.A., Inc. announced today that UroPartners, the largest urology practice in Illinois and top five in the nation, has chosen to standardize on the Persona CT computed tomography (CT) system to accelerate their oncology treatment planning capabilities
News | Computed Tomography (CT)
Fujifilm Announces CT Partnership with Leading Urology Group UroPartners

December 17, 2020 — Fujifilm Medical Systems U.S.A., Inc. announced that UroPartners, the largest urology practice in ...

Time December 17, 2020
arrow
Primary liver cancer is on the rise worldwide, largely due to an increase in hepatitis C infections and chronic liver disease
News | Radiation Therapy
A First-in-human Clinical Trial Shows Microbubbles Augments Radiation in Liver Cancer Patients

December 16, 2020 — Primary liver cancer is on the rise worldwide, largely due to an increase in hepatitis C infections ...

Time December 16, 2020
arrow
The first MRI-guided radiation therapy system provides real-time view of tumors during radiation treatment
News | Radiation Therapy
Hoag Brings Groundbreaking Cancer Treatment Technology to Orange County

December 15, 2020 — Hoag Memorial Hospital Presbyterian became the only hospital in Orange County, and one of the first ...

Time December 15, 2020
arrow
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium
News | Radiation Therapy
Omitting Radiation Therapy After Breast-conserving Surgery May Not Impact 10-year Survival Rates

December 15, 2020 — Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy ...

Time December 15, 2020
arrow
CXCR4-directed PET correlates with MRI-determined lymphoma lesions. Depicted are representative MR images (T1c- and FLAIR- sequences), and the corresponding CXCR4- directed PET images and fusion images (MRI-FLAIR and PET), of two patients with PCNSL and SCNSL, respectively. Images created by Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
News | PET Imaging
PET Imaging Tracer Effective for Diagnosing and Managing Rare CNS B-cell Lymphoma

December 14, 2020 — Positron emission tomography (PET) imaging with 68Ga-pentixafor is an effective diagnostic tool for ...

Time December 14, 2020
arrow
Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was common in reports of pain, pruritus, edema and fatigue, with younger patients and Black patients having significantly increased odds of symptom under-recognition, according to data presented at the 2020 San Antonio Breast Cancer Symposium
News | Women's Health
Under-recognition of Symptoms May Be Common in Breast Cancer Patients Receiving Radiation

December 14, 2020 — Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was ...

Time December 14, 2020
arrow
A new study finds that significant symptoms in young and Black patients are more likely to be under-recognized
News | Radiation Therapy
Physicians Don't Always Recognize Patients' Radiation Therapy Side Effects

December 10, 2020 — Physicians did not recognize side effects from radiation therapy in more than half of breast cancer ...

Time December 10, 2020
arrow
Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma
News | PET-MRI
PET/MRI, CT Metrics Assess Pathologic Response of Pancreas Cancer to Neoadjuvant Therapy

December 10, 2020 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR) ...

Time December 10, 2020
arrow
Latest iteration of Philips IntelliSite Pathology Solution helps support pathologists to work more efficiently in an automated digital workflow
News | Digital Pathology
Philips Boosts Digital Pathology with Enhanced Informatics to Advance Precision Diagnosis in Oncology

December 7, 2020 — Philips, a global leader in health technology, today announced it will introduce its latest ...

Time December 07, 2020
arrow
16% of people believe they have developed a medical condition since the coronavirus crisis started but have not seen a doctor because they worry about getting COVID-19
News | Coronavirus (COVID-19)
Study Shows Decline in Medical Visits Due to COVID-19 Fear

December 7, 2020 — New research* from Zegami, an Oxford based medical image analysis platform, reveals that 29% of ...

Time December 07, 2020
arrow
A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray
New Hybrid X-ray Detector Goes Toe-to-toe with State-of-the-art Rivals

December 3, 2020 — A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — ...

Time December 03, 2020
arrow
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
News | Prostate Cancer
Radiation Therapy Has the Greatest Impact on Patient Finances

December 2, 2020 — For men with early-stage prostate cancer, choices about initial treatment carry varying risks of ...

Time December 02, 2020
arrow
Sponsored Content | Sponsored Content | Videos | Information Technology
Talking Trends with Elekta

Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements ...

Time December 01, 2020
arrow
 Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their manufacturing partner Nucleis (Liege, Belgium) has manufactured and shipped their first patient doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, currently under evaluation in clinical trials in men with newly diagnosed prostate cancer and suspected prostate cancer recurrence.
News | PET Imaging
Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent in Collaboration with Nucleis Radiopharmaceuticals

November 25, 2020 — Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their ...

Time November 25, 2020
arrow
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)
News | Computed Tomography (CT)
GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition

November 25, 2020 — GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up ...

Time November 25, 2020
arrow
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.
News | Prostate Cancer
Men with Negative Biopsies During Active Surveillance Have Good Outcomes

November 18, 2020 — Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"- ...

Time November 18, 2020
arrow
Radiation oncologists across the country will meet virtually with members of Congress this week to discuss value-based payment, prior authorization and supporting cancer care during the pandemic
News | Radiation Oncology
Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

November 18, 2020 — Radiation oncologists across the country will meet virtually with members of Congress this week to ...

Time November 18, 2020
arrow
Videos | Radiation Therapy
VIDEO: Explaining Boron Neutron Capture Therapy for Targeted Cancer Radiotherapy

Bruce Bauer, Ph.D., CEO of TAE Life Sciences. The company is developing boron neutron capture therapy (BNCT) as a new ...

Time November 15, 2020
arrow
Minimizing delays to treatment could improve cancer survival rates, say researchers
News | Radiation Oncology
Every Month Delayed in Cancer Treatment Can Raise Risk of Death by Around 10%

November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher ...

Time November 10, 2020
arrow
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality
News | Prostate Cancer
Active Surveillance Safe for African Americans with Low-risk Prostate Cancer

November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from prostate ...

Time November 04, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now